Dutch Heath Minister Accused Of Polarizing Medicine Price Debate
Dutch Health Minister Bruno Bruins has attacked pharmaceutical companies over their drug pricing practices, and has threatened to name and shame one particular firm.
You may also be interested in...
The Netherlands will secure lower medicine prices by referencing Norway instead of Germany to set maximum prices.
A new Dutch foundation set up to address cases of what it says are excessive drug pricing says it plans to refer Leadiant Biosciences’ CDCA product for the rare genetic disease, cerebrotendinous xanthomatosis, to the competition authorities.
Brazil’s health technology assessment institute is to incorporate cost-effectiveness thresholds into its decision making.